Skip to content

MEDCARE

Active
Private limited companyfounded 20242 yrs activeVlasendaalstraat 71, 1700 Dilbeek, BelgiumKBO/BCE: BE 1011.482.841
Summary

MEDCARE has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €8,102 and a net result of €32,955. Its solvency ranks better than 11% of 16718 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability99▼-1
Solvency31▼-4
Growth52
Track record82
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €500 at 30 days acceptable
Liquidity tight (current ratio 1.08 against 1.02 in 2024; short-term debt: 73.1% and cash: 69.6% of total assets), and 94% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
6%
Return on assets
24.5%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 11% of 16718 sector peers (2025).
NBB · sector comparison
Position among 16718 sector peers
Solvency
better than 11%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-07-2026, 15 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
15 d early
2024
28 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 7 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 12 July 2024, MEDCARE was incorporated as a Private limited company.1 The company has filed 2 sets of annual accounts, the latest for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€8,102▲ 13.4%
2024 · €7,146
Total assets
€134,403▲ 83.5%
2024 · €73,259
Net result
€32,955▼ 50.2%
2024 · €66,146
Working capital
€7,827▲ 406%
2024 · €1,548
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20242025
Operating result€66,824-€33,209▼ 50.3%
Net result€66,146within the sector's middle half-€32,955within the sector's middle half▼ 50.2%
Equity€7,146below the sector's middle half-€8,102below the sector's middle half▲ 13.4%
Total assets€73,259below the sector's middle half-€134,403within the sector's middle half▲ 83.5%
Debt€66,112-€126,301▲ 91.0%
Working capital€1,548-€7,827▲ 406%
Solvency9.8%below the sector's middle half-6.0%below the sector's middle half▼ 3.7pp
above within below the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€20,000€40,000€60,000Operating result 2024: €66,824€66,824Net result 2024: €66,146€66,146Operating result 2025: €33,209€33,209Net result 2025: €32,955€32,95520242025€0€20,000€40,000€60,000Operating result 2024: €66,824€66,800Net result 2024: €66,146€66,100Operating result 2025: €33,209€33,200Net result 2025: €32,955€33,00020242025
The operating result falls in 2025; 2025 is 50% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €134,403
Fixed assets €28,326 ▲ 400%
Current assets €106,077 ▲ 56.9%
Equity and liabilities €134,403
Equity €8,102 ▲ 13.4%
Debt €126,301 ▲ 91.0%
Debt's share of the balance-sheet total rises from 90.2% to 94.0%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€36,529▼
2024 · €66,905
Cash flow
€36,276▼
2024 · €66,227
Current ratio
1.08▲
2024 · 1.02
Debt to equity
15.59▲
2024 · 9.25
ROE
406.8%▼
2024 · 925.6%
ROA
24.5%▼
2024 · 90.3%
Interest coverage
424.81▼
2024 · 2211.73
Debt ≤ 1 year
€98,250▲
2024 · €66,042
Income taxes
€169▼
2024 · €647
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 2,155 companies that looked in July 2024 the way this one looks now, 2.6% went bankrupt within 24 months and 94% are still going.

  • Micro
  • 2 to 5 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
2.6% went bankrupt
2.6% stopped otherwise
94% still going

A further 0.7% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.6%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 2,155 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 38 lines
Balance sheet Code20242025
Assets
Total assets20/58€73,259€134,403▲
Fixed assets21/28€5,669€28,326▲
Tangible fixed assets22/27€5,669€28,326▲
Plant, machinery and equipment23€5,669€25,648▲
Furniture and vehicles24-€2,677
Current assets29/58€67,590€106,077▲
Amounts receivable within one year40/41€1,307€1,264▼
Other amounts receivable41€1,307€1,264▼
Cash at bank and in hand54/58€60,254€93,575▲
Deferred charges and accrued income490/1€6,029€11,238▲
Equity and liabilities
Total equity and liabilities10/49€73,259€134,403▲
Equity10/15€7,146€8,102▲
Contributions10/11€6,000€6,000=
Profit (loss) carried forward14€1,146€2,102▲
Amounts payable17/49€66,112€126,301▲
Amounts payable within one year42/48€66,042€98,250▲
Trade debts44€395€497▲
Suppliers440/4€395€497▲
Taxes, remuneration and social security45€647€169▼
Taxes450/3€647€169▼
Other amounts payable47/48€65,000€97,584▲
Accrued charges and deferred income492/3€70€28,051▲
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€81€3,321▲
Other operating charges640/8-€1,423
Gross operating margin9900€66,905€37,952▼
Operating profit (loss)9901€66,824€33,209▼
Financial income75/76B-€1
Recurring financial income75-€1
Financial charges65/66B€30€86▲
Recurring financial charges65€30€86▲
Profit (loss) for the period before taxes9903€66,794€33,124▼
Income taxes67/77€647€169▼
Profit (loss) for the period9904€66,146€32,955▼
Profit (loss) for the period to be appropriated9905€66,146€32,955▼
Appropriation of the result
Profit (loss) to be appropriated9906€66,146€34,102▼
Profit (loss) brought forward from the previous period14P-€1,146
Profit to be distributed694/7€65,000€32,000▼
Directors or managers695€65,000€32,000▼

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€81€3,321▲ 4,001%
Other operating charges640/8-€1,423-
Gross operating margin9900€66,905€37,952▼ 43.3%
Operating profit (loss)9901€66,824€33,209▼ 50.3%
Financial income75/76B-€1-
Recurring financial income75-€1-
Financial charges65/66B€30€86▲ 184%
Recurring financial charges65€30€86▲ 184%
Profit (loss) for the period before taxes9903€66,794€33,124▼ 50.4%
Income taxes67/77€647€169▼ 73.9%
Profit (loss) for the period9904€66,146€32,955▼ 50.2%
Profit (loss) for the period to be appropriated9905€66,146€32,955▼ 50.2%
Line20242025Change
Assets
Total assets20/58€73,259€134,403▲ 83.5%
Fixed assets21/28€5,669€28,326▲ 400%
Tangible fixed assets22/27€5,669€28,326▲ 400%
Plant, machinery and equipment23€5,669€25,648▲ 352%
Furniture and vehicles24-€2,677-
Current assets29/58€67,590€106,077▲ 56.9%
Amounts receivable within one year40/41€1,307€1,264▼ 3.3%
Other amounts receivable41€1,307€1,264▼ 3.3%
Cash at bank and in hand54/58€60,254€93,575▲ 55.3%
Deferred charges and accrued income490/1€6,029€11,238▲ 86.4%
Equity and liabilities
Total equity and liabilities10/49€73,259€134,403▲ 83.5%
Equity10/15€7,146€8,102▲ 13.4%
Contributions10/11€6,000€6,000=
Profit (loss) carried forward14€1,146€2,102▲ 83.3%
Amounts payable17/49€66,112€126,301▲ 91.0%
Amounts payable within one year42/48€66,042€98,250▲ 48.8%
Trade debts44€395€497▲ 25.9%
Suppliers440/4€395€497▲ 25.9%
Taxes, remuneration and social security45€647€169▼ 73.9%
Taxes450/3€647€169▼ 73.9%
Other amounts payable47/48€65,000€97,584▲ 50.1%
Accrued charges and deferred income492/3€70€28,051▲ 39,847%
Line20242025Change
Profit (loss) for the period9904€66,146€32,955▼ 50.2%
+ Depreciation and write-downs630€81€3,321▲ 4,001%
Operating cash flow (approximation)€66,227€36,276▼ 45.2%
Investment in fixed assets (approximation)--€25,977-
Change in cash-€33,321-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
16-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
28-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 28 days late
NBB filing
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Dilbeek · 1 establishment unit since 2024
seat establishment The establishment unit on the map
Ground area
862 m²
Building footprint
182 m²
Volume, LiDAR
751 m³
Parcel 23352G0211/00G000, Flanders · tallest building 8.0 m, ±1 floor. Linked by address, not a title deed.
5 companies at this address See who is registered here
1 establishment unit
MEDCARE
Vlasendaalstraat 71, 1700 DilbeekHuman health activities
since 20242.361.993.253
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23352G0211/00G000 Flanders 861 m² 1 · 182 m² 8.0 m · 1 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 12,699 companies in sector 86951 we hold annual accounts for 2,146. 1,401 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded12-07-2024
Fiscal year end31-12
Activities, NACEBEL 2025
86951Physiotherapy
E-invoicing
Reachable via Peppol
Peppol ID 0208:1011482841
Also 9925:BE1011482841
Registered 28-09-2024

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.